Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab

Conditions: Early Breast Cancer; Triple Negative Breast Cancer Interventions: Drug: Pembrolizumab injection Sponsors: Fundacao Champalimaud Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials